financetom
Business
financetom
/
Business
/
What's Going On With Palantir Technologies Shares Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Palantir Technologies Shares Today?
Jun 28, 2024 7:58 AM

Palantir Technologies Inc. ( PLTR ) shares are trading marginally higher on Friday.

Peter Thiel, Chairman of Palantir Technologies ( PLTR ), shared his outlook on the future in an NBC News interview. He focused on AI, digital currencies, and his views on America’s current state.

In an interview with BNN Bloomberg, Dan Ives, an analyst at Wedbush Securities, dismissed the notion that Palantir ( PLTR ) is not at the forefront of cutting-edge technology and sales.

Read This: Dan Ives Labels Nvidia Correction A ‘Near-Term Pullback’, Hails Palantir As ‘Purest AI Name’ Amid Growing Market Use Cases

He emphasized Palantir’s recent developments, labeling the company as the “purest AI name in the market in terms of use cases.” Ives expressed optimism about Palantir’s future, stating that “monetization is gonna play out” as the industry enters the second derivative of AI.

Earlier this month, Argus Research analyst Joseph Bonner initiated coverage on the stock with a Buy rating and announced a price target of $29, highlighting momentum around the company’s commercial business.

The Argus Research analyst noted that Palantir ( PLTR ) has significantly improved its profitability and cash flow in recent years. 

Yesterday, the company inked a pact with Voyager Space. Together, Voyager and Palantir ( PLTR ) will advance the space and defense technology sectors by integrating Palantir’s AI tools across the Voyager enterprise.

Palantir ( PLTR ) reported earnings for the first quarter last month. Despite beating estimates on the top and bottom lines and raising its full-year guidance, the stock traded lower. It has since recovered as software and AI continue to be dominant themes in the market.

Palantir ( PLTR ) is due to report earnings in early August. The company is expected to report earnings of 8 cents per share and revenue of $652.139 million, according to Benzinga Pro.

Check This Out: Palantir And Voyager Space Strengthen Alliance To Boost Defense And Space Tech With AI Integration

Price Action: PLTR shares are trading higher by 0.93% to $25.47 at last check Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved